Dubai to host ‘World Biohack Summit’

DUBAI, United Arab Emirates–(BUSINESS WIRE)–Dubai, which is emerging as the wellness and fitness hub of the world is now set to witness Asia’s first ever World Biohack Summit (WBHS) on May 30, 31 – 2023 at Grand Hyatt. Sajeev Nair, co-founder & chairman of Limoverse Technologies, the host of the event said, “This is an … [Read more…]

Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs)

WILMINGTON, Del. & TOKYO–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre® (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of myeloid/lymphoid neoplasms (MLNs) with FGFR1 fusion (also known as 8p11 myeloproliferative syndrome). MLNs are a rare, aggressive group of cancers characterized … [Read more…]

Cellusion Announces First Patient Transplanted iPSC-Derived Corneal Endothelial Cell Substitute (CLS001)

– Short-term safety was confirmed. Efficacy including visual acuity and corneal thickness is improving. TOKYO–(BUSINESS WIRE)–Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at the 22nd Japanese Society for Regenerative Medicine Annual Conference (Kyoto, Japan, March 23-25, 2023) … [Read more…]

ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced final overall survival data and an evaluation of sequence of therapy in the pivotal SORAYA trial of mirvetuximab soravtansine in patients with folate receptor alpha-high platinum-resistant ovarian cancer who had been previously … [Read more…]

Gordon Moore, Intel Co-Founder, Dies at 94

Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy. SANTA CLARA, Calif.–(BUSINESS WIRE)–Intel and the Gordon and Betty Moore Foundation announced today that company co-founder Gordon Moore has passed away at the age of 94. The foundation reported he died peacefully on Friday, March 24, 2023, … [Read more…]

Cutera Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-K

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on March 21, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing … [Read more…]

MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update

Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2 Go-To-Market trial (THIO-102) Presented preclinical data validating efficacy of THIO in hepatocellular carcinoma at SITC Annual Meeting Held pre-IND meeting with FDA for planned U.S. expansion of THIO Advanced new telomere-targeting molecule program CHICAGO–(BUSINESS WIRE)–MAIA … [Read more…]

ClinAI Chooses The Sales Ops Group to Accelerate Sales Transformation and Drive Value Proposition Alignment

LOS GATOS, Calif. & SAN FRANCISCO–(BUSINESS WIRE)–#AcceleratedSalesExecution–The Sales Ops Group, the sales strategy and transformation consulting company that accelerates the sales capabilities of many of the world’s top brands, today announced that ClinAI, the leader in clinical trial selection and RFP software has selected its consulting solutions to deliver a repeatable go-to-market sales process and … [Read more…]

Resilience Approved for $410M Financing from the Department of Defense, in Partnership with the Development Finance Corporation, to Establish Resilient Biomanufacturing Capacity

Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids SAN DIEGO–(BUSINESS WIRE)–#biomanufacturing–National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced that it has signed a finance agreement for $410 million in long-term loan financing from the U.S. Department of Defense (DoD), working … [Read more…]

7,000 U.S. Tuberculosis Patients Across 700 Health Departments Reach 700,000 Medication Check-Ins with Scene Health

BALTIMORE–(BUSINESS WIRE)–Today, on World Tuberculosis Day, Scene Health (formerly emocha Health) is proud to announce a milestone of 7,000 patients being supported and over 700,000 video check-ins submitted since 2013 across 700 public health departments in the U.S. including 14 states and territories and 5 of the ten largest counties by population. According to the … [Read more…]